Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
genetic analysis
Research
Regeneron researchers identify promising new NASH target
A recent study from Regeneron researchers points to genetic mutations in a specific gene as protective against liver diseases, including NASH.
Max Bayer
Aug 2, 2022 1:20am
FDA warns against reliance on genetic prenatal screening tests
Apr 20, 2022 11:27am
LetsGetChecked adds genetic sequencing to at-home testing slate
Mar 29, 2022 6:00am
Discovery of genetic variants could aid new acne treatments
Feb 7, 2022 11:51am
RNA sequencing enhances pediatric cancer diagnoses: study
Jan 28, 2022 2:13pm
23andMe snags 3rd FDA nod for genetic cancer risk test
Jan 10, 2022 11:58am
